QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
191 hedge funds and large institutions have $3.5B invested in QIAGEN NV in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 79 increasing their positions, 57 reducing their positions, and 21 closing their positions.
276% more call options, than puts
Call options by funds: $312K | Put options by funds: $83K
39% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 57
14% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 21
5% more capital invested
Capital invested by funds: $3.34B → $3.5B (+$162M)
1% more funds holding
Funds holding: 190 → 191 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.1M |
| 2 |
Axa
Paris,
France
|
+$17.2M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$16M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$11.3M |
| 5 |
O
OppenheimerFunds
New York
|
+$8.58M |
Top Sellers
| 1 |
Primecap Management
Pasadena,
California
|
-$36.6M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$31.4M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$21.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$19.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$18.2M |
QGENF Hedge Fund Activity: Q4 2015 in Review
191 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q4 2015, worth a combined $3.5B — up 4.9% from $3.34B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new QGENF positions and 21 closed out — a net gain of 3 holders — while 79 added to existing stakes and 57 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $20.1M. The largest seller was Primecap Management, cutting an estimated $36.6M.
- 191 institutional investors held QIAGEN NV (QGENF) as of Q4 2015, up from 190 in Q3 2015.
- Funds reported $3.5B of QIAGEN NV stock for Q4 2015, up 4.9% quarter-over-quarter.
- 24 funds opened new QIAGEN NV positions in Q4 2015 and 21 closed out, a net change of +3 holders.
- The largest QIAGEN NV buyer in Q4 2015 was Deutsche Bank, an estimated $20.1M added.
- The largest QIAGEN NV seller in Q4 2015 was Primecap Management, an estimated $36.6M sold.
Based on aggregated 13F filings for Q4 2015.